Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Mr Duncan Chui

28 Sep 2012 18:27

RNS Number : 5264N
China Private Equity Inv Hldgs Ld
28 September 2012
 



 

28 September 2012

 

 

 

China Private Equity Investment Holdings Limited (AIM: CPEH)

 

("CPE" or the "Company")

 

Mr Duncan Chui

 

Further to the announcement of 28 August 2012, China Private Equity Investments Holdings Limited (AIM: CPEH) announces the following further information regarding Mr Duncan Chui, the Company's Chief Investment Officer (who is not a director of the Company), in relation to the censure of him by the Market Misconduct Tribunal in Hong Kong ("MMT") (the "Censure"),

 

The Censure relates to dealings by Mr Chui in the shares of a Hong Kong Stock Exchange listed company, Sino Katalytics Investment Corporation ("SKIC") which is unrelated to the Company, and which were undertaken in January 2009, prior to CPE being admitted to trading on AIM in October 2009. The report of the MMT concluded that Mr Chui was culpable of false trading, price rigging and stock market manipulation. As a result, the MMT has ordered that Mr Chui should not act as a director or take part in the management of a listed company for a period of two years, which Mr Chui has been advised relates to Hong Kong listed companies. Further, Mr Chui is not permitted, directly or indirectly, to deal in securities in Hong Kong and he has been ordered to pay aggregate costs to the Government of Hong Kong and the Hong Kong Securities and Futures Commission of HK$1.3 million.

 

The board of directors of the Company (the "Board") reiterates that the day to day management of the Company has not changed and there is no impact on the portfolio of CPE's investments as a result of the MMT decision. Specifically, the proposed listing of Fortel BVI continues to progress, with the listing application anticipated to be submitted to the Hong Kong Stock Exchange by the end of this year, as set out in the Company's interim results for the six months to 30 June 2012, announced on 26 September 2012. Mr Chui is not a director of any of CPE's investee companies and he does not participate in the day to day management of these companies.

 

Mr Chui has strongly denied the allegations made against him and has launched an appeal against the decisions of the MMT.

 

The MMT reports can be found on the MMT website at www.mmt.gov.hk.

 

For further information, please visit www.cpe-invest.comor contact:

 

Maria Leung, China Private Equity Investment Holdings Ltd:

 

Azhic Basirov / Siobhan Sergeant,

Smith & Williamson Corporate Finance Ltd:

 

Allan Piper, First City Public Relations (Hong Kong):

 

Simon Hudson, Tavistock Communications (London):

 

www.cpe-invest.com

 

+852 2801 6770

 

 

+44 (0) 20 7131 4000

 

+852 2854 2666

 

+44 (0) 20 7920 3170

 

Ticker symbol: CPEH

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSELFWAFESEEU
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.